Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Pilot Study to Determine the Optimal Negative Pressure of EVERA-RAPHA for Non-invasive Breast Augmentation in Women

NCT04185961 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04185961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04185961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Pilot Study to Determine the Optimal Negative Pressure of EVERA-RAPHA for Non-invasive Breast Augmentation in Women
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2020
Completion date
April 6, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast hypoplasia